A set of clinical trials led by Russian for the first Covid-19 vaccine have had successful results.
The Sechenov First Moscow State Medical University said in a statement on its website that it began clinical trials of the vaccine against Sars-Cov-2, on June 18. The vaccine was produced by Russia’s Gamaleya Institute of Epidemiology and Microbiology.
In the process, around 20 people volunteered for the injection and after being given the shot, the volunteers were asked to quarantine in the hospital for 28 days.
According to a TASS newswire Sunday report, the chief researcher for the Russian
Center for Clinical Research Medications at Sechenov University, Elena Smolyarchuk
has told the research has been completed and it proved that the vaccine is safe. The
volunteers will be discharged on July 15 and July 20.
According to the World Health Organisation, there are at least 21 vaccines currently under trial worldwide.
However, no trial other information was mentioned regarding a date when this vaccine would enter commercial production.
As reported from Moscow this weekend, public health officials lifted the requirement of wearing face masks while outside. Masks and gloves are mandatory when using public transportation, going to a medical center, or while shopping.